Transcatheter Pulmonary Valve Market Size, Share, Trends, Growth Outlook

Transcatheter Pulmonary Valve Market is estimated to increase at a growth rate of 6.4% CAGR over the forecast period from 2024 to 2030.

The global Transcatheter Pulmonary Valve Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Application (Cardiac Anomaly, Pulmonary Atresia, Pulmonary Stenosis, Pulmonary Regurgitation, Tetralogy of Fallot, Truncus Arteriosus, Others), By Technology (Balloon-Expanded Transcatheter Valve, Self-Expanded Transcatheter Valve), By End-user (Adult, Pediatric), By Raw Material (Synthetic Transcatheter Valve, Tissue Engineered Transcatheter Valve).

An introduction to Transcatheter Pulmonary Valve Market in 2024

In 2024, the transcatheter pulmonary valve market is thriving, propelled by advancements in pediatric cardiology, congenital heart interventions, and the growing demand for minimally invasive treatment options for patients with congenital heart defects, right ventricular outflow tract (RVOT) dysfunction, or pulmonary valve regurgitation. Transcatheter pulmonary valves encompass a variety of bioprosthetic valves, valve-in-valve devices, and transcatheter delivery systems used for percutaneous pulmonary valve replacement (PPVR) or valve repair in patients with dysfunctional or stenotic pulmonary valves, enabling improved hemodynamics, reduced right ventricular volume overload, and preserved pulmonary artery growth in pediatric and adult patients with congenital heart disease. With innovations in valve design, delivery systems, and patient-specific modeling, the market is experiencing rapid expansion and adoption of transcatheter pulmonary valves, offering pediatric cardiologists, congenital heart surgeons, and interventional radiologists innovative and less invasive options for managing pulmonary valve dysfunction, improving RVOT function, and optimizing long-term cardiac outcomes in patients with complex congenital heart defects, driving advancements in pediatric cardiac interventions and transcatheter valve therapies.

Transcatheter Pulmonary Valve Market Trend: Expansion of Indications and Applications Drives Growth in the Transcatheter Pulmonary Valve Market

A significant trend in the transcatheter pulmonary valve market is the expansion of indications and applications beyond congenital heart defects to include acquired pulmonary valve diseases and other structural heart conditions. Technological advancements have enabled the development of transcatheter pulmonary valve devices that offer less invasive treatment options for patients with pulmonary valve dysfunction due to congenital anomalies, pulmonary regurgitation, or pulmonary stenosis. Additionally, innovative transcatheter techniques, such as percutaneous pulmonary valve implantation (PPVI) and transcatheter pulmonary valve-in-valve (ViV) procedures, provide alternatives to surgical interventions, catering to a broader patient population. This trend reflects the growing recognition of transcatheter approaches as viable treatment options for various pulmonary valve disorders, driving market expansion and adoption.

Transcatheter Pulmonary Valve Market Driver: Growing Demand for Minimally Invasive Treatment Options Propels the Transcatheter Pulmonary Valve Market

The increasing demand for minimally invasive treatment options serves as a significant driver for the transcatheter pulmonary valve market. Patients and healthcare providers alike seek alternatives to traditional open-heart surgery, particularly for congenital heart defects and other structural heart conditions affecting the pulmonary valve. Transcatheter pulmonary valve interventions offer several advantages over surgical procedures, including reduced recovery times, shorter hospital stays, and lower procedural risks. As healthcare systems prioritize patient-centered care and minimally invasive approaches, the demand for transcatheter pulmonary valve devices continues to rise, supporting market growth and innovation.

Transcatheter Pulmonary Valve Market Opportunity: Advancements in Transcatheter Techniques Offer Opportunities for Innovation in the Transcatheter Pulmonary Valve Market

The advancement of transcatheter techniques presents a promising opportunity for innovation in the transcatheter pulmonary valve market. Emerging transcatheter procedures, such as balloon pulmonary valvuloplasty, transcatheter pulmonary valve-in-ring (ViR) procedures, and percutaneous pulmonary valve replacement (PPVR), offer new avenues for the treatment of pulmonary valve disorders. These techniques enable tailored interventions for patients with diverse anatomical variations and clinical presentations, enhancing procedural success rates and patient outcomes. Furthermore, ongoing research and development efforts aim to improve device design, delivery systems, and long-term durability of transcatheter pulmonary valve devices, addressing unmet clinical needs and expanding the potential applications of transcatheter interventions in the treatment of pulmonary valve diseases. Capitalizing on this opportunity requires collaboration between medical device manufacturers, interventional cardiologists, and cardiac surgeons to drive innovation and advance transcatheter techniques in the evolving landscape of pulmonary valve interventions.

Transcatheter Pulmonary Valve Market Market Segmentation

By Application
Cardiac Anomaly
Pulmonary Atresia
Pulmonary Stenosis
Pulmonary Regurgitation
Tetralogy of Fallot
Truncus Arteriosus
Others
By Technology
Balloon-Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
By End-User
Adult
Pediatric
By Raw Material
Synthetic Transcatheter Valve
Tissue Engineered Transcatheter Valve

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Transcatheter Pulmonary Valve Market Companies

Artivion Inc
Boston Scientific Corp
Braile Biomedica
Edwards Lifesciences Corp
JenaValve Technology Inc
LivaNova PLC
Medtronic PLC
Venus Medtech

Reasons to Buy the Transcatheter Pulmonary Valve Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Transcatheter Pulmonary Valve Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Transcatheter Pulmonary Valve Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Transcatheter Pulmonary Valve Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Transcatheter Pulmonary Valve Market Size Outlook, $ Million, 2021 to 2030
3.2 Transcatheter Pulmonary Valve Market Outlook by Type, $ Million, 2021 to 2030
3.3 Transcatheter Pulmonary Valve Market Outlook by Product, $ Million, 2021 to 2030
3.4 Transcatheter Pulmonary Valve Market Outlook by Application, $ Million, 2021 to 2030
3.5 Transcatheter Pulmonary Valve Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Transcatheter Pulmonary Valve Industry
4.2 Key Market Trends in Transcatheter Pulmonary Valve Industry
4.3 Potential Opportunities in Transcatheter Pulmonary Valve Industry
4.4 Key Challenges in Transcatheter Pulmonary Valve Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Transcatheter Pulmonary Valve Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Transcatheter Pulmonary Valve Market Outlook by Segments
7.1 Transcatheter Pulmonary Valve Market Outlook by Segments, $ Million, 2021- 2030
By Application
Cardiac Anomaly
Pulmonary Atresia
Pulmonary Stenosis
Pulmonary Regurgitation
Tetralogy of Fallot
Truncus Arteriosus
Others
By Technology
Balloon-Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
By End-User
Adult
Pediatric
By Raw Material
Synthetic Transcatheter Valve
Tissue Engineered Transcatheter Valve

8 North America Transcatheter Pulmonary Valve Market Analysis and Outlook To 2030
8.1 Introduction to North America Transcatheter Pulmonary Valve Markets in 2024
8.2 North America Transcatheter Pulmonary Valve Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Transcatheter Pulmonary Valve Market size Outlook by Segments, 2021-2030
By Application
Cardiac Anomaly
Pulmonary Atresia
Pulmonary Stenosis
Pulmonary Regurgitation
Tetralogy of Fallot
Truncus Arteriosus
Others
By Technology
Balloon-Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
By End-User
Adult
Pediatric
By Raw Material
Synthetic Transcatheter Valve
Tissue Engineered Transcatheter Valve

9 Europe Transcatheter Pulmonary Valve Market Analysis and Outlook To 2030
9.1 Introduction to Europe Transcatheter Pulmonary Valve Markets in 2024
9.2 Europe Transcatheter Pulmonary Valve Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Transcatheter Pulmonary Valve Market Size Outlook by Segments, 2021-2030
By Application
Cardiac Anomaly
Pulmonary Atresia
Pulmonary Stenosis
Pulmonary Regurgitation
Tetralogy of Fallot
Truncus Arteriosus
Others
By Technology
Balloon-Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
By End-User
Adult
Pediatric
By Raw Material
Synthetic Transcatheter Valve
Tissue Engineered Transcatheter Valve

10 Asia Pacific Transcatheter Pulmonary Valve Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Transcatheter Pulmonary Valve Markets in 2024
10.2 Asia Pacific Transcatheter Pulmonary Valve Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Transcatheter Pulmonary Valve Market size Outlook by Segments, 2021-2030
By Application
Cardiac Anomaly
Pulmonary Atresia
Pulmonary Stenosis
Pulmonary Regurgitation
Tetralogy of Fallot
Truncus Arteriosus
Others
By Technology
Balloon-Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
By End-User
Adult
Pediatric
By Raw Material
Synthetic Transcatheter Valve
Tissue Engineered Transcatheter Valve

11 South America Transcatheter Pulmonary Valve Market Analysis and Outlook To 2030
11.1 Introduction to South America Transcatheter Pulmonary Valve Markets in 2024
11.2 South America Transcatheter Pulmonary Valve Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Transcatheter Pulmonary Valve Market size Outlook by Segments, 2021-2030
By Application
Cardiac Anomaly
Pulmonary Atresia
Pulmonary Stenosis
Pulmonary Regurgitation
Tetralogy of Fallot
Truncus Arteriosus
Others
By Technology
Balloon-Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
By End-User
Adult
Pediatric
By Raw Material
Synthetic Transcatheter Valve
Tissue Engineered Transcatheter Valve

12 Middle East and Africa Transcatheter Pulmonary Valve Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Transcatheter Pulmonary Valve Markets in 2024
12.2 Middle East and Africa Transcatheter Pulmonary Valve Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Transcatheter Pulmonary Valve Market size Outlook by Segments, 2021-2030
By Application
Cardiac Anomaly
Pulmonary Atresia
Pulmonary Stenosis
Pulmonary Regurgitation
Tetralogy of Fallot
Truncus Arteriosus
Others
By Technology
Balloon-Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
By End-User
Adult
Pediatric
By Raw Material
Synthetic Transcatheter Valve
Tissue Engineered Transcatheter Valve

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Artivion Inc
Boston Scientific Corp
Braile Biomedica
Edwards Lifesciences Corp
JenaValve Technology Inc
LivaNova PLC
Medtronic PLC
Venus Medtech
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Application
Cardiac Anomaly
Pulmonary Atresia
Pulmonary Stenosis
Pulmonary Regurgitation
Tetralogy of Fallot
Truncus Arteriosus
Others
By Technology
Balloon-Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
By End-User
Adult
Pediatric
By Raw Material
Synthetic Transcatheter Valve
Tissue Engineered Transcatheter Valve